GLOBAL BIO-SIMULATION MARKET RESEARCH AND FORECAST 2018-2023 Orion Market Research
DEFINITION Bio-simulation applications such as preclinical testing, clinical trials, target identification and validation, lead identification and optimization are widely adopted. These applications enable to provide faster and more certain results compared to conventional techniques as a result it is widely adopted across the globe.
MARKET MOTIVATORS • Global rise in adoption of drug discovery and • development • Growing adoption of personalized medicines • Technological advancement and innovation in • global bio-simulation market • Cohesive government policies and regulations • Global rise in healthcare expenditure
MARKET RESTRAINTS • High cost of bio-simulation is a concern for the • market • Chances of error in bio-simulation model • development approaches • Software for large scale bio-simulations may • create problem and complexity
MARKET OPPORTUNITIES Global rise in pharmaceutical market is expected to boost the global bio-simulation market R&D outcomes of drug development in next few years are expected to drive the global bio-simulation market Clinical trials are predicted to increase in next few years Reduction in late stage attrition
MARKET PLAYERS • Accelrys • Biovia • Certara • Chemical Computing Group • Compugen • Dassault Systèmes • Entelos Holding Corporation • Genedata • To Be Continued……
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 +91-7803040404 +1-6467557667 email@example.com www.omrglobal.com https://www.omrglobal.com/industry-reports/biosimulation-market/